Lipoprotein(a): Recognizing and Managing a Hidden Cardiovascular Risk

Overview

Lipoprotein (a) or Lp(a) is a powerful, independent, genetically determined risk factor for cardiovascular disease. On a per particle basis, Lp(a) is approximately 6X more atherogenic than LDL-Cholesterol as it has pro-atherosclerotic, pro-thrombotic, and pro-inflammatory properties.

20% of Americans have an elevated level of Lp(a) but the prevalence is even higher in women, African-Americans, and South Asians. Most professional societies recommend screening all adults for Lp(a) at least once in a lifetime and yet the diagnosis rate for elevated Lp(a) is currently <5%.

The Family Heart Foundation is a non-profit, patient advocacy organization that supports people with inherited cholesterol disorders, including elevated Lp(a). Please join us for this engaging session to learn more about an emerging risk factor for cardiovascular disease, the latest screening recommendations, and practical management strategies to reduce CV risk in those with elevated Lp(a).